Strata Critical Medical, Inc. (SRTA)

From the record

Strata Critical Medical, Inc.'s filings since 2019 show 3 warning events of 3 kinds: a warning not to rely on past financial statements (8-K item 4.02, the latest 2021-04-28); an auditor change (8-K item 4.01, the latest 2024-03-22); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2021-05-18) (its current reports).

From the record

Strata Critical Medical, Inc.'s 7 filed years say what it did: revenue went from $31 million in fiscal 2019 to $197 million in fiscal 2025, up 34.3% a year; it rose in 4 of 6 years; the deepest fall was 35% from fiscal 2023 to fiscal 2024; net income was positive in 2 of 9 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Strata Critical Medical, Inc. earned about 15 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 13 cents per dollar of everything the company owns. Leverage: it owed about 14 cents per dollar of assets, and net share issuance: its share count grew 5.9% over the year (the filed statements).

From the record

Strata Critical Medical, Inc.'s standing among 14 graded names in its industry family: revenue of $197 million in fiscal 2025 ranks in the bottom 25% by size; a net margin of 21% ranks in the top 4%; revenue growth of 10.5% a year over the last 3 filed years ranks in the bottom 18% (its annual reports).

From the record

Strata Critical Medical, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Heyburn, William A. (Co-CEO and CFO, as filed), filing under that title since 2025-09-12, 1.2 years (bottom 5% of its family); the 10 officers and directors filing in the last fifteen months have been on the record a median of 5.3 years (top 23%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 10 people in charge now (bottom 38%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Strata Critical Medical, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $31 million against no long-term debt tagged leaves 9.6% of its assets as net cash, bottom 46% of its family; cash from operations less capital spending is -29.7% of revenue (bottom 18%); a gross margin of 20.9% (bottom 19%) (its annual report).

From the record

Strata Critical Medical, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 10.5% a year over the last three filed years against 34.3% over all 7, slowing (bottom 18% of its family); the newest year grew 34.3% (top 39%); capital spending grew 136% a year (top 19%) (its annual reports). Strata Critical Medical, Inc. reported 2 lines of business in fiscal 2025: Logistics at $177 million (90%), Clinical at $20 million (10%); 1 of 1 grew against the year before (its annual report).

From the record

Strata Critical Medical, Inc.'s newest year against its own record: revenue of $197 million in fiscal 2025 came in 34% above the $147 million its prior three years' pace pointed to (top 21% of its family); net income of $41 million against a prior three-year average of $37 million (top 4%); a net margin of 21% against -20.7% before (top 21%) (its annual reports).